Clinical trial
Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
NCT00157651 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00157651 |
|---|---|
| Title | Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters |
| Official title | A Double-Blind, Placebo Controlled, Randomized Trial of Low-Intensity Adjusted-Dose Warfarin for the Prevention of Mechanical Malfunction of Double-Lumen Haemodialysis Catheters |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | End Stage Renal Disease, Thrombosis, Bleeding |
| Intervention type | Drug |
| Interventions | warfarin, placebo |
| Enrollment | 170 |
| Start date | Feb 1, 1999 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 17, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: